910 Participants Needed

Primary Care Program for Breast Cancer Management

SV
Overseen ByShawna V Hudson, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This mixed methods study evaluates the effectiveness of an organizational intervention to enhance implementation of strategies to increase breast cancer survivorship symptom and risk management.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Practice Led Intervention in the Primary Care Program for Breast Cancer Management?

The research suggests that coordination between primary care and oncology care providers is important for quality cancer care, but there is limited evidence on the effectiveness of specific interventions. However, a pilot study indicated that breast cancer patients might benefit from targeted actions by general practitioners based on multidisciplinary team recommendations.12345

How does the Primary Care Program for Breast Cancer Management differ from other treatments?

This treatment is unique because it focuses on transitioning breast cancer survivors from specialist care to primary care, ensuring that they receive continuous and evidence-based follow-up care from primary care providers. This approach is designed to be safe and effective, providing a sustainable model for managing survivorship care.678910

Research Team

SV

Shawna V Hudson, PhD

Principal Investigator

Rutgers University

Eligibility Criteria

This trial is for staff members or patients who have had breast cancer and are part of a participating practice. They must be able to speak, understand, and read English as well as provide informed consent.

Inclusion Criteria

You work at the clinic or have been a patient there and have had breast cancer.

Exclusion Criteria

I am unable to understand and give consent for treatment.
Unable to speak, understand and/or read English

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

Implementation of intervention strategies including practice facilitation, expert consultation, collaborative learning events, and audit and feedback

6 months
Baseline assessment and intervention activities

Follow-up

Participants are monitored for effectiveness of the intervention and sustainability of follow-up care, symptom, and risk management activities

18 months
Assessments at 6, 12, 18, and 24 months

Treatment Details

Interventions

  • Practice Led Intervention
Trial Overview The study is testing an organizational intervention aimed at improving the management of symptoms and risks in breast cancer survivors within primary care settings.
Participant Groups
2Treatment groups
Active Control
Group I: Practice Led InterventionActive Control1 Intervention
Clinic staff will participate in learning collaborative and practice facilitation as well as receive expert consultation and audit and feedback.
Group II: Standard of CareActive Control1 Intervention
No intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

References

Interventions to improve care coordination between primary healthcare and oncology care providers: a systematic review. [2021]
Breast cancer follow-up: could primary care be the right venue? [2016]
Cancer care coordinator: promoting multidisciplinary care--a pilot study in Australian general practice. [2022]
The development of a new site-specific measure of quality of life for breast problems: the Cardiff breast scales. [2019]
Patient satisfaction with breast cancer follow-up care provided by family physicians. [2021]
Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data. [2022]
Learning the landscape: implementation challenges of primary care innovators around cancer survivorship care. [2022]
Are primary care providers implementing evidence-based care for breast cancer survivors? [2022]
Breast Cancer Survivorship Tool: Facilitating breast cancer survivorship care for family physicians and patients. [2023]
10.United Statespubmed.ncbi.nlm.nih.gov
Supporting models to transition breast cancer survivors to primary care: formative evaluation of a cancer care Ontario initiative. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security